Related Experiment Video
Updated: May 26, 2026
06:51
A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Juvenile angiofibroma: evolution of management
Piero Nicolai1, Alberto Schreiber, Andrea Bolzoni Villaret
1Department of Otorhinolaryngology, University of Brescia, Piazza Spedali Civili 1, 25123 Brescia, Italy.
International Journal of Pediatrics
|December 14, 2011
Summary
Juvenile angiofibroma, a rare nasal tumor in adolescent males, is best treated with surgery. Advances in preoperative embolization and endoscopic techniques have improved outcomes and reduced complications.
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Pediatric Oncology
Background:
- Juvenile angiofibroma is a rare, benign tumor arising from the pterygopalatine fossa.
- It typically affects adolescent males presenting with epistaxis and nasal obstruction.
Purpose of the Study:
- To review the evolution of juvenile angiofibroma management.
- To highlight recent diagnostic and therapeutic advancements.
Main Methods:
- Literature review focusing on diagnostic and surgical techniques.
- Analysis of treatment outcomes, including complications and residual disease.
- Comparison of endoscopic versus external surgical approaches.
Main Results:
- Surgery remains the primary treatment for juvenile angiofibroma.
- Preoperative embolization significantly reduces surgical complications and bleeding.
- Endoscopic techniques are effective alternatives for small-to-intermediate sized tumors.
Conclusions:
- Modern management emphasizes a multidisciplinary approach.
- Advancements in embolization and endoscopic surgery have improved treatment efficacy and patient safety.
- Continued research is vital for further refining juvenile angiofibroma treatment strategies.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...